Health IT Generated PROs to Improve Outcomes in Cirrhosis
Key facts
- Who runs it
- Virginia Commonwealth University
- Where
- Richmond and Rochester, United StatesSee the 3 sites
- Trial code
- Status
- Completed
- People taking part
- 232 people enrolled
- Started
- 22 Jun 2018
- Ended
- 22 May 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Health-IT +/- Scheduled Follow Up
- Record updated
- 17 September 2025
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Other criteria
- Patient Inclusion Criteria:
- Cirrhosis patients ≥21 years of age hospitalized for non-elective reasons
- Adult caregiver and the patient living in the same house
- Able to complete the Patient Buddy training and evaluation
- Discharged home from the hospital
- Discharge hospital as primary hospital base; Caregiver Inclusion Criteria:
- Living in same dwelling as patient for the last ≥1 year
- Able to complete the Patient Buddy training and evaluation
- Familiar with the patient's routine; Patient Exclusion Criteria:
- Elective hospitalization
- Lack of an adult caregiver
- Active substance abuse within 1 month of the hospitalization (alcohol use is acceptable provided the patient does not have alcoholic hepatitis during this admission or <1 month prior to admission)
- Unable to perform training or give consent
- Patients discharged to hospice, nursing home or extended care facilities
- pregnant women
- patients with limited English proficiency; Caregiver Exclusion Criteria
- Unable or unwilling to train or adhere to study guidelines
- Unfamiliar with the patient routines
- Not in the same house as the patient
Where in United States
- Hunter Holmes McGuire VA Medical CenterRichmond, United States
- Virginia Commonwealth UniversityRichmond, United States
- Mayo ClinicRochester, United States
About the trial
What the trial wants to find out
SPECIFIC AIM 1: To evaluate in a multi-center, randomized trial the effectiveness of PROs elicited using PatientBuddy and EncephalApp on the prevention of avoidable 30 day readmissions in patients with cirrhosis and their caregivers compared to standard of care.
The 2 groups in the trial
- Control GroupNo study treatment, for comparison
Standard of care counseling and discharge instructions per local hospital policy. Standard of care follow up phone calls and visits at baseline and at 30 days. Follow-up will be for 30 days
- Health IT +/- Scheduled Follow UpTreatment being tested
Subjects and caregivers will be given individual phones loaded with the Patient Buddy App and the EncephalApp that will be used to enter medications, issues and orientation questions daily. There will be messages and phone calls as needed per the App and visits will be at baseline, scheduled at 15 days and at 30 days. In addition, scheduled phone calls will be performed at days 7 and 21.Follow-up will be for 30 days
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study.Journal of medical Internet research, 2021
- Record updated
- 17 September 2025